by
Thomas Dworetzky, Contributing Reporter | January 07, 2020
The study is in line with others that looked at AI to catch cancer in mammograms, Connie Lehman, chief of the breast imaging department at Harvard’s Massachusetts General Hospital, told Reuters.
The study shows the promise of such software, but it did not show that the use of AI, which could potentially spot cancers radiologists could not with the human eye, is improving patient treatment at present.
Ad Statistics
Times Displayed: 113248
Times Visited: 6741 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
“AI software is only helpful if it actually moves the dial for the radiologist,” Dr. Lisa Watanabe, chief medical officer of CureMetrix, an AI mammography provider, told Reuters.
Author Etemadi concurred, acknowledging that more studies are needed.
In December 2019, a report by MIT Technology Review Insights and GE Healthcare, which surveyed more than 900 healthcare professionals in the U.S. and the U.K., showed that
80 percent are looking to put more money into AI.
"Today, AI is being deployed at a scale where we can move from speculating about its potential for healthcare to tracking it," said Kieran Murphy, president and CEO of GE Healthcare, in a statement. "From increasing the time healthcare providers can spend with patients to advancing preventive care, we are tremendously encouraged by the trends emerging across the health ecosystem.”
Back to HCB News
